Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activator
- 15 November 1989
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 14 (6) , 1570-1571
- https://doi.org/10.1016/0735-1097(89)90400-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- Thrombolytic reperfusion of acute myocardial infarction: Resolved and unresolved issuesJournal of the American College of Cardiology, 1988
- Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Molecular mechanism of action of newer thrombolytic agentsJournal of the American College of Cardiology, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionJournal of the American College of Cardiology, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985